Rock Point Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Rock Point Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-348	Closed	-$202K	–	126
2025 Q4	$202K	Sell	348 -200	-36%	-$113K	0.05%	119
2025 Q3	$266K	Hold	548	–	–	0.07%	96
2025 Q2	$222K	Hold	548	–	–	0.06%	100
2025 Q1	$273K	Hold	548	–	–	0.08%	88
2024 Q4	$285K	Hold	548	–	–	0.08%	85
2024 Q3	$339K	Hold	548	–	–	0.09%	85
2024 Q2	$303K	Sell	548 -50	-8%	-$28.6K	0.09%	84
2024 Q1	$348K	Sell	598 -30	-5%	-$16.8K	0.1%	80
2023 Q4	$333K	Sell	628 -10	-2%	-$4.84K	0.1%	76
2023 Q3	$323K	Sell	638 -20	-3%	-$10.7K	0.11%	79
2023 Q2	$343K	Sell	658 -7	-1%	-$3.78K	0.11%	73
2023 Q1	$383K	Buy	665 +143	+27%	+$80.6K	0.13%	71
2022 Q4	$287K	Hold	522	–	–	0.1%	81
2022 Q3	$265K	Hold	522	–	–	0.1%	76
2022 Q2	$284K	Hold	522	–	–	0.1%	76
2022 Q1	$308K	Hold	522	–	–	0.09%	76
2021 Q4	$348K	Hold	522	–	–	0.1%	74
2021 Q3	$298K	Hold	522	–	–	0.09%	75
2021 Q2	$263K	Hold	522	–	–	0.08%	84
2021 Q1	$238K	Hold	522	–	–	0.07%	85
2020 Q4	$243K	Buy	522 +22	+4%	+$10.3K	0.08%	79
2020 Q3	$221K	Buy	+500	New	+$207K	0.1%	77

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Rock Point Advisors's TMO Position: Q1 2026 in Review

Rock Point Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 348 shares — an estimated $202K sold.

Rock Point Advisors first reported a position in TMO in Q3 2020 and held it in 22 quarters. The position peaked at $383K in Q1 2023. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Rock Point Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
Rock Point Advisors sold 348 Thermo Fisher Scientific shares in Q1 2026, an estimated $202K.
Rock Point Advisors first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 22 quarters.
Rock Point Advisors's Thermo Fisher Scientific position peaked at $383K in Q1 2023.
2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Rock Point Advisors's 13F filing for Q1 2026, filed 14 May 2026.